Skip to playerSkip to main contentSkip to footer
Fast Company
  • 3/8/2018
The FDA approved the company to check for breast cancer-related gene mutations during genetic testing, but there are some caveats.

Recommended

6:09
Up next
Pour a cold one for your dog with Anheuser-Busch’s latest brew
Fast Company
20:35
The future of LGBTQ+ inclusion in the workplace
Fast Company
18:42
The founders of Philadelphia International Records look back at 50 years of Philly Soul
Fast Company
3:07
The founders of Philadelphia International Records look back at 50 amazing years
Fast Company
11:34
How American Ballet Theatre bounced back after losing all revenue due to COVID
Fast Company
3:25
Creative agency Mischief is bringing fun back to advertising
Fast Company
4:00
Brandlive reinvents the long and tedious all hands meeting
Fast Company
35:12
This new bamboo sneaker is changing the shoe industry
Fast Company
1:44
3 ways you can resist the urge to multitask
Fast Company
4:14
Budweiser skips the Super Bowl, and Robinhood’s reputation takes a tumble—brand hit and miss of the week
Fast Company
1:54
4 ways to approach difficult conversations as a leader
Fast Company
1:48
3 mistakes many women make on their résumés and how to fix them
Fast Company
2:04
5 steps to create better boundaries when you work from home
Fast Company
1:53
3 time management myths that could be hurting your productivity
Fast Company
4:08
How to celebrate non-romantic love this Valentine's Day
Fast Company
1:48
4 ways to refresh your résumé
Fast Company
1:56
4 ways to cultivate creativity
Fast Company
1:25
3 ways to build influence at work
Fast Company
2:50
3 keys to building a healthy remote company
Fast Company
1:40
4 ways to improve your brainstorm sessions
Fast Company
1:34
3 tips for fostering stronger relationships in a virtual world
Fast Company
1:38
4 tips that can help you close a deal remotely
Fast Company
3:24
4 leadership tactics that build trust
Fast Company
1:58
4 effective ways to use Instagram in your job search
Fast Company
5:40
What one of Google's top AI ethics researchers had to say before the company pushed her out
Fast Company